These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4058940)

  • 1. [Experimental therapy of acute thrombosis using a tissue plasminogen activator].
    Paradeeva IK; Osipov SN; Rugal' VI; Shabalin VN
    Patol Fiziol Eksp Ter; 1985; (4):61-4. PubMed ID: 4058940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activator treatment of acute venous thrombosis (author's transl)].
    Jester HG
    Dtsch Med Wochenschr; 1978 Dec; 103(48):1922-5. PubMed ID: 710320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ilio-femoral vein thrombosis treated with tissue plasminogen activator in a pregnant woman].
    Grand A; Ghadban W; Perret SP; Saboul R; Mosnier S; Douieb A; Fichter P; Huret JF
    Ann Cardiol Angeiol (Paris); 1996 Nov; 45(9):517-22. PubMed ID: 9033705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of potentiation and rapid action in models of venous thrombosis in dogs upon combined administration of the plasminogen tissue activator and urokinase modified by fibrinogen].
    Maksimenko AV; Tishchenko EG; Petrova ML; Golubykh VL
    Biull Eksp Biol Med; 1996 Jan; 121(1):48-51. PubMed ID: 8680005
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog.
    Clare AC; Kraje BJ
    J Am Vet Med Assoc; 1998 Feb; 212(4):539-43. PubMed ID: 9491162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Venous immunomorphology in acute experimental thrombosis and human recurrent migrating thrombophlebitis].
    Dameniia LE; Shakhanina KL; Beletskaia LV
    Arkh Patol; 1981; 43(3):47-52. PubMed ID: 7236032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinolytic therapy of deep vein thrombosis of the leg and pelvis with streptokinase and urokinase].
    Hasler K; Neumann H
    Med Welt; 1983 Oct; 34(43):1225-9. PubMed ID: 6645913
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombotic therapy principles in acute thromboses of the major veins].
    Il'in VN; Rodionov SV; Zaĭtseva LA; Erkhov VI
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):89-94. PubMed ID: 7314407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early surgery for iliac-femoral post-thrombotic syndrome and related experimental study].
    Yin MY; Huang XT; Jiang ME
    Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):972-6. PubMed ID: 21054978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.
    Weimar W; Stibbe J; van Seyen AJ; Billiau A; De Somer P; Collen D
    Lancet; 1981 Nov; 2(8254):1018-20. PubMed ID: 6118479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinolysis and thrombolysis after administration of tissue plasminogen activator in dogs].
    Malinovskiĭ NN; Andreenko GV; Maksimovich IV; Shimonaeva EE; Liutova LV
    Vestn Akad Med Nauk SSSR; 1985; (7):52-8. PubMed ID: 4050079
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic and thrombolytic properties of a plasminogen activator isolated from the culture broth of calf kidney cells].
    Egorov BB; Andreenko GV; Liaginskiĭ AV; Stelingovskií KV; Podorol'skaia LV
    Farmakol Toksikol; 1983; 46(4):54-6. PubMed ID: 6684592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tissue plasminogen activator: mechanism of action and thrombolytic properties].
    Páramo JA; Collen D
    Sangre (Barc); 1984; 29(4-C):767-73. PubMed ID: 6393389
    [No Abstract]   [Full Text] [Related]  

  • 16. [The therapeutic approach in puerperal sepsis].
    Pranchev N
    Akush Ginekol (Sofiia); 1996; 35(1-2):57-8. PubMed ID: 8967547
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment of iliofemoral thrombosis in a 12-year-old boy].
    Khanes GS
    Pediatr Akus Ginekol; 1973; 6():31. PubMed ID: 4786368
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental thrombolysis by perfusion. II. Comparative study on the effect of streptokinase, urokinase and plasmin.
    Egeblad K; Bertelsen S
    Acta Chir Scand; 1969; 135(6):486-90. PubMed ID: 4244115
    [No Abstract]   [Full Text] [Related]  

  • 19. [Loco-regional fibrinolysis in the treatment of acute, non-traumatic ischemia of an artery. Use of PTFE, homologous vein, and Dacron in the treatment of acute thrombosis].
    Palombi M; Sposato S; Stefanuto A; Bochicchio O; Gargiulo M; Berardi F; D'Elia G
    Minerva Chir; 1998 Dec; 53(12):1015-25. PubMed ID: 10210932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase.
    Noerr B
    Neonatal Netw; 1996 Dec; 15(8):66-8. PubMed ID: 9035655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.